|Table of Contents|

The cycle of dormant cancer cells

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:
2023 02
Page:
392-394
Research Field:
Publishing date:

Info

Title:
The cycle of dormant cancer cells
Author(s):
ZHANG Baihong1YUE Hongyun2
1.Department of Oncology;2.Department of Ophtalmology,the 940th Hospital of Joint Logistics Support Force of People's Liberation Army,Gansu Lanzhou 730050,China.
Keywords:
tumour dormancytumor buddingtumor reawakeningtherapy
PACS:
R730.5
DOI:
10.3969/j.issn.1672-4992.2023.02.039
Abstract:
Cell dormancy is a reversible quiescence state.The dormant cancer cells life cycle have quiescence,reawakening,budding,and seeding four phases,which can cause cancer relapse.The current strategies targeting cancer cell dormancy include keeping cancer cells in the dormant state,eradicating dormant cancer cells and inducing dormant cancer cells to enter senescent state.

References:

[1]PHAN TG,CROUCHER PI.The dormant cancer cell life cycle[J].Nat Rev Cancer,2020,20(7):398-411.
[2]WERNER-KLEIN M,KLEIN CA.Therapy resistance beyond cellular dormancy[J].Nat Cell Biol,2019,21(2):117-119.
[3]BOUMAHDI S,DE SAUVAGE FJ.The great escape:tumour cell plasticity in resistance to targeted therapy[J].Nat Rev Drug Discov,2020,19(1):39-56.
[4]RECASENS A,MUNOZ L.Targeting cancer cell dormancy[J].Trends Pharmacol Sci,2019,40(2):128-141.
[5]BELL CC,GILAN O.Principles and mechanisms of non-genetic resistance in cancer[J].Br J Cancer,2020,122(4):465-472.
[6]TALUKDAR S,BHOOPATHI P,EMDAD L,et al.Dormancy and cancer stem cells:An enigma for cancer therapeutic targeting[J].Adv Cancer Res,2019,141:43-84.
[7]PRUNIER C,BAKER D,TEN DIJKE P,et al.tgf-β family signaling pathways in cellular dormancy[J].Trends Cancer,2019,5(1):66-78.
[8]BADO I,ZHANG XH.Senesce to survive:YAP-mediated dormancy escapes EGFR/MEK inhibition[J].Cancer Cell,2020,37(1):1-2.
[9]EMMA RISSON,ANA RITA NOBRE,VERONIQUE MAGUER-SATTA.The current paradigm and challenges ahead for the dormancy of disseminated tumor cells[J].Nature Cancer,2020,1:672-680.
[10]CORREIA AL,GUIMARAES JC,MAUR PA,et al.Hepatic stellate cells suppress NK cell-sustained breast cancer dormancy[J].Nature,2021,594(7864):566-571.
[11]SINHA G,FERRER AI,MOORE CA,et al.Gap junctions and breast cancer dormancy[J].Trends Cancer,2020,6(4):348-357.
[12]AGUIRRE-GHISO JA.How dormant cancer persists and reawakens[J].Science,2018,361(6409):1314-1315.
[13]DART A.Waking up in a trap[J].Nat Rev Cancer,2018,18(12):722-723.
[14]FOX DB,GARCIA NMG,MCKINNEY BJ,et al.NRF2 activation promotes the recurrence of dormant tumour cells through regulation of redox and nucleotide metabolism[J].Nat Metab,2020,2(4):318-334.
[15]LUGLI A,ZLOBEC I,BERGER MD,et al.Tumour budding in solid cancers[J].Nat Rev Clin Oncol,2021,18(2):101-115.
[16]ZLOBEC I,LUGLI A.Tumour budding in colorectal cancer:molecular rationale for clinical translation[J].Nat Rev Cance,2018,18(4):203-204.
[17]CELIA-TERRASSA T,KANG Y.Metastatic niche functions and therapeutic opportunities[J].Nat Cell Biol,2018,20(8):868-877.
[18]MIAO Y,YANG H,LEVORSE J,et al.adaptive immune resistance emerges from tumor-initiating stem cells[J].Cell,2019,177(5):1172-1186.
[19]GKOUNTELA S,CASTRO-GINER F,SZCZERBA BM,et al.Circulating tumor cell clustering shapes DNA methylation to enable metastasis seeding[J].Cell,2019,176(1-2):98-112.
[20]JIANG MJ,GU DN,DAI JJ,et al.Dark side of cytotoxic therapy:Chemoradiation-induced cell death and tumor repopulation[J].Trends Cancer,2020,6(5):419-431.
[21]MOREL D,JEFFERY D,ASPESLAGH S,et al.Combining epigenetic drugs with other therapies for solid tumours-past lessons and future promise[J].Nat Rev Clin Oncol,2020,17(2):91-107.
[22]BONNAY F,VOLOS A,STEINMANN V,et al.Oxidative metabolism drives immortalization of neural stem cells during tumorigenesis[J].Cell,2020,182(6):1490-1507.
[23]KINOUCHI K,SASSONE-CORSI PS.Metabolic rivalry:circadian homeostasis and tumorigenesis[J].Nat Rev Cancer,2020,20(11):645-661.
[24]HOFBAUER LC,BOZEC A,RAUNER M,et al.Novel approaches to target the microenvironment of bone metastasis[J].Nat Rev Clin Oncol,2021,18(8):488-505.
[25]MANJILI MH.The premise of personalized immunotherapy for cancer dormancy[J].Oncogene,2020,39(22):4323-4330.
[26]SENFT D,JEREMIAS I.Tumor cell dormancy-triggered by the niche[J].Dev Cell,2019,49(3):311-312.
[27]CARLSON P,DASGUPTA A,GRZELAK CA,et al.Targeting the perivascular niche sensitizes disseminated tumour cells to chemotherapy[J].Nat Cell Biol,2019,21(2):238-250.
[28]TAJAN M,VOUSDEN KH.Dietary approaches to cancer therapy[J].Cancer Cell,2020,37(6):767-785.
[29]ROY S,TRINCHIERI G.Microbiota:a key orchestrator of cancer therapy[J].Nat Rev Cancer,2017,17(5):271-285.
[30]GATENBY RA,BROWN JS.Integrating evolutionary dynamics into cancer therapy[J].Nat Rev Clin Oncol,2020,17(11):675-686.
[31]GORGOULIS V,ADAMS PD,ALIMONTI A.Cellular senescence:defining a path forward[J].Cell,2019,179(4):813-827.
[32]SHEN S,VAGNER S,ROBERT C.Persistent cancer cells:the deadly survivors[J].Cell,2020,183(4):860-874.
[33]GOMEZ K,RABADAN R.A persistent look at how tumours evade therapy[J].Nature,2021,596(7873):491-493.

Memo

Memo:
中国人民解放军联勤保障部队九四〇医院院内课题(编号:2021yxky052)
Last Update: 1900-01-01